Combining in Vivo Metabolism and Whole-Body Biodistribution for Comprehensive Insight into ERAP2 Inhibitor Pharmacokinetic


Explore our innovative research combining in vivo metabolism and whole-body biodistribution to gain comprehensive insights into the pharmacokinetics of an ERAP2 inhibitor. By comparing traditional liquid assays with advanced mass spectrometry imaging, we reveal the stability and biodistribution of the compound.

Download our poster to learn more.

Download Now